Hemophilia B Gene Therapy - Spark

This study is currently recruiting participants.
Verified December 2013 by Spark Therapeutics, LLC
Sponsor:
Collaborators:
Children's Hospital of Philadelphia
University of Pittsburgh
Royal Prince Alfred Hospital, Sydney, Australia
St. James's Hospital, Ireland
Information provided by (Responsible Party):
Spark Therapeutics, LLC
ClinicalTrials.gov Identifier:
NCT01620801
First received: June 12, 2012
Last updated: December 20, 2013
Last verified: December 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: October 2029
  Estimated Primary Completion Date: October 2019 (Final data collection date for primary outcome measure)